Back to User profile » Dr Hiroki Osumi
Papers published by Dr Hiroki Osumi:
Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study
Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K
Cancer Management and Research 2019, 11:5757-5764
Published Date: 25 June 2019
Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake
Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K
OncoTargets and Therapy 2018, 11:8301-8307
Published Date: 23 November 2018
Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer
Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K
Cancer Management and Research 2018, 10:5283-5290
Published Date: 1 November 2018
Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab
Osumi H, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
OncoTargets and Therapy 2015, 8:2005-2013
Published Date: 6 August 2015